PAYMENT REVIEW OF

EVERRNA MEDICINES (SINGAPORE) PTE. LTD.

18 JANUARY 2026

EVERRNA MEDICINES (SINGAPORE) PTE. LTD. (ABN: 202210102K) is a business entity in Singapore registered with The Accounting and Corporate Regulatory Authority (ACRA) and is currently operational. It has a payment reputation rating of 'B' under our scoring framework, and all transactions are recorded in Singapore Dollars (SGD).
Good: 3

Registrar Details

Entity Name
EVERRNA MEDICINES (SINGAPORE) PTE. LTD.
UEN
202210102K
Entity Status
Live Company
Constitution
Data unavailable
Entity Type
Local Company
Primary Activity (SSIC)
46461
Wholesale of medicinal and pharmaceutical products (Western)
Secondary Activity (SSIC)
72101
Research and experimental development on biotechnology (except medical and veterinary science)
Issuance Agency
ACRA
Registration Incorporation Date
24 March 2022
UEN Issue Date
24 March 2022
Registered Address
36 ROBINSON ROAD CITY HOUSE #20-01 SINGAPORE 68877
Number of Officers
10
Financial Reporting
Account Due Date
31 July 2025
Annual Return Date
07 August 2024
Audit Firms
Data unavailable
Former Names
  1. EVERVAC MEDICINES (SINGAPORE)

User Reviews
0

Loading reviews...

Review Anonymously

Help others understand EVERRNA MEDICINES (SINGAPORE) PTE. LTD.'s payment practices.
B
Payment Rating

Going Concern

PASSED

Legal Name

EVERRNA MEDICINES (SINGAPORE) PTE. LTD.

Registration Number

202210102K

Country Jurisdiction

SINGAPORE

Registered Date

24 MARCH 2022 (4 years 0 months ago)

Base Currency

SINGAPORE DOLLARS

Last Updated

18 JANUARY 2026 10:57 PM

Legal Invoice Recovery
Make a claim on EVERRNA MEDICINES (SINGAPORE) PTE. LTD.

Frequently Asked Questions

The Payment Rating of EVERRNA MEDICINES (SINGAPORE) PTE. LTD. is B. It is a proprietary metric aggregating verified public sources (court judgements, news media, financial analysis), community feedback and data partnerships. It indicates the likelihood of on-time payments but is not a financial guarantee.

EVERRNA MEDICINES (SINGAPORE) PTE. LTD. has passed the "Going Concern" test. This suggest that EVERRNA MEDICINES (SINGAPORE) PTE. LTD. is operationally active and is likely to be able to meet financial obligations. More specifically, it means EVERRNA MEDICINES (SINGAPORE) PTE. LTD. does not have significant reported poor payment reviews that is cause for distress and it is also not in the process of being liquidated, winding up, or struck off from the government registry.

Based on the registration date of 24 MARCH 2022 12:00 AM, EVERRNA MEDICINES (SINGAPORE) PTE. LTD. is approximately 4 years old.

The business registration number of EVERRNA MEDICINES (SINGAPORE) PTE. LTD. is 202210102K. The business registration number is a standard identification number assigned by government registrar to uniquely identify a business entity.

EVERRNA MEDICINES (SINGAPORE) PTE. LTD. is officially located at 36 ROBINSON ROAD CITY HOUSE #20-01 SINGAPORE 68877. This is the registered address on file with the registrar.

EVERRNA MEDICINES (SINGAPORE) PTE. LTD.'s primary industry is Wholesale of medicinal and pharmaceutical products (Western) (SSIC code: 46461) and secondary industry is Research and experimental development on biotechnology (except medical and veterinary science) (SSIC code: 72101).

No. We are an open business directory and review platform. We do not issue credit ratings like Experian, Equifax, or Moody's. Our data, including Payment Ratings, should be used for reference only, not as the sole basis for financial decisions.

Business profile information is provided by official government registries, such as ACRA in Singapore, Australian Business Register, New Zealand Companies Register, and Companies House in the United Kingdom. Payment ratings and reviews are sourced from court notices or judgements, news media, financial analysis, data partnerships and user reported reviews.

Yes. Your identity is protected—reviews are published under the display name 'Anonymous' so businesses cannot identify who wrote them.​ While we verify that reviewers have a legitimate connection to the business (such as being a real supplier or customer), this verification happens privately and is never shared publicly. This approach mirrors how Glassdoor (and Reddit) protects reviewers from retaliation while ensuring reviews come from real people. Avoid including identifying details in your review text (like specific invoice numbers, unique transaction dates, or your company name) that could make you recognizable.

As an open platform, Payre democratizes payment risk information that would otherwise be expensive or difficult to access through traditional credit bureaus. You can share and read actual creditor experiences about late or non-payments to promote a prompt payment culture, influence debtor's management practice and help others make better decisions. We promise reviews to remain freely accessible to anyone.